Cargando…
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
The human papillomavirus (HPV) vaccine plays an important role in preventing a series of diseases caused by HPV. Recent studies have shown that as a primary prevention measure, it can considerably prevent HPV infection and HPV-associated cervical cancer. However, studies on the safety, efficacy, and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365840/ https://www.ncbi.nlm.nih.gov/pubmed/32754157 http://dx.doi.org/10.3389/fimmu.2020.01434 |
_version_ | 1783560106057662464 |
---|---|
author | Zhou, Xu Sun, Lihua Yao, Xiaoxiao Li, Guangquan Wang, Yicun Lin, Yang |
author_facet | Zhou, Xu Sun, Lihua Yao, Xiaoxiao Li, Guangquan Wang, Yicun Lin, Yang |
author_sort | Zhou, Xu |
collection | PubMed |
description | The human papillomavirus (HPV) vaccine plays an important role in preventing a series of diseases caused by HPV. Recent studies have shown that as a primary prevention measure, it can considerably prevent HPV infection and HPV-associated cervical cancer. However, studies on the safety, efficacy, and coverage of the HPV vaccine remain insufficient, especially in developing countries. Therefore, in this review, we outlined the recent studies of the HPV vaccine in terms of immunogenicity, safety, efficacy, latest vaccination concepts, and strategies. This review may provide a theoretical basis for use of the HPV vaccine. |
format | Online Article Text |
id | pubmed-7365840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73658402020-08-03 Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine Zhou, Xu Sun, Lihua Yao, Xiaoxiao Li, Guangquan Wang, Yicun Lin, Yang Front Immunol Immunology The human papillomavirus (HPV) vaccine plays an important role in preventing a series of diseases caused by HPV. Recent studies have shown that as a primary prevention measure, it can considerably prevent HPV infection and HPV-associated cervical cancer. However, studies on the safety, efficacy, and coverage of the HPV vaccine remain insufficient, especially in developing countries. Therefore, in this review, we outlined the recent studies of the HPV vaccine in terms of immunogenicity, safety, efficacy, latest vaccination concepts, and strategies. This review may provide a theoretical basis for use of the HPV vaccine. Frontiers Media S.A. 2020-07-10 /pmc/articles/PMC7365840/ /pubmed/32754157 http://dx.doi.org/10.3389/fimmu.2020.01434 Text en Copyright © 2020 Zhou, Sun, Yao, Li, Wang and Lin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhou, Xu Sun, Lihua Yao, Xiaoxiao Li, Guangquan Wang, Yicun Lin, Yang Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title | Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title_full | Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title_fullStr | Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title_full_unstemmed | Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title_short | Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine |
title_sort | progress in vaccination of prophylactic human papillomavirus vaccine |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365840/ https://www.ncbi.nlm.nih.gov/pubmed/32754157 http://dx.doi.org/10.3389/fimmu.2020.01434 |
work_keys_str_mv | AT zhouxu progressinvaccinationofprophylactichumanpapillomavirusvaccine AT sunlihua progressinvaccinationofprophylactichumanpapillomavirusvaccine AT yaoxiaoxiao progressinvaccinationofprophylactichumanpapillomavirusvaccine AT liguangquan progressinvaccinationofprophylactichumanpapillomavirusvaccine AT wangyicun progressinvaccinationofprophylactichumanpapillomavirusvaccine AT linyang progressinvaccinationofprophylactichumanpapillomavirusvaccine |